[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Endocrinology](https://durgical.com/en/endocrinology/) › [Diabetes](https://durgical.com/en/endocrinology/areas/diabetes/) › Hypoglycaemia: the Whipple triad, insulin and C-peptide

# Hypoglycaemia: the Whipple triad, insulin and C-peptide

- Diagnostic approach

A low [blood sugar](https://durgical.com/en/biochemistry/molecules/glucose/) can cause confusion, seizures and death. With diabetes, treatment is usually the cause; without it, a test taken during the low finds it.

Updated Nov 15, 2026

**See it in 3D:** [Pancreas](https://durgical.com/en/anatomy/pancreas/)

## Key points

- Whipple triad: symptoms + documented low glucose + relief with glucose.
- Insulin high + C-peptide low = injected insulin.
- Insulin high + C-peptide high → sulfonylurea (screen positive) or [insulinoma](https://durgical.com/en/conditions/insulinoma/) (screen negative).
- Insulin low + ketones high = starvation-type causes.
- Sulfonylurea lows recur: observe.

On this page

- The basics Key points
- What it is
- How to think about it
- What to know
- Step-by-step approach
- Reading the critical sample during hypoglycaemia
- Common traps
- Elsewhere in DurgiPedia

- Clinical Keys to the differential

- Treatment Next step / Initial management

- Study Test yourself

- Connections Connections

## What it is

In people treated for diabetes, [hypoglycaemia](https://durgical.com/en/conditions/hypoglycaemia/) is almost always caused by insulin or insulin secretagogues ([sulfonylureas](https://durgical.com/en/pharmacology/classes/sulfonylureas/), meglitinides), with a missed meal, exercise, alcohol or falling kidney function as triggers. In people without diabetes, hypoglycaemia is first proven by the Whipple triad: symptoms, a low plasma glucose (below about 55 mg/dL, 3.0 mmol/L) measured at the time, and relief when glucose is raised. Then a «critical sample» taken during the low (insulin, C-peptide, proinsulin, beta-hydroxybutyrate and a screen for secretagogues) shows the mechanism. In ill patients the usual causes are drugs, sepsis, [liver](https://durgical.com/en/anatomy/liver/) or kidney failure, [adrenal insufficiency](https://durgical.com/en/conditions/adrenal-insufficiency/), starvation and tumours that make IGF-2; in seemingly well people, insulinoma, hypoglycaemia [after bariatric surgery](https://durgical.com/en/endocrinology/endocrine-care-after-bariatric-surgery/), insulin autoimmunity and covert use of insulin or sulfonylureas.

## How to think about it

C-peptide is the receipt that comes with every insulin molecule the [pancreas](https://durgical.com/en/anatomy/pancreas/) makes. Insulin without a receipt was injected. Insulin with a receipt was made in the body, either by a tumour or because a drug told the beta cells to release it, and a drug screen tells those two apart.

## What to know

- In diabetes care: level 1 is glucose below 70 mg/dL, level 2 below 54 mg/dL, and level 3 is any episode that needs another person's help.
- Warning symptoms (adrenergic and cholinergic): tremor, palpitations, sweating, hunger, anxiety. Brain-glucose symptoms: confusion, odd behaviour, seizures, coma.
- Repeated episodes blunt the warning symptoms (hypoglycaemia unawareness); weeks without hypoglycaemia can restore them.
- Sulfonylurea hypoglycaemia is prolonged and recurs, especially in older people and kidney failure.
- Beta-blockers blunt tremor and palpitations, but sweating remains.
- Insulinoma: fasting or exercise-induced lows, often with weight gain; small and usually benign; part of MEN1 in some patients.
- After [gastric bypass](https://durgical.com/en/conditions/bariatric-surgery-and-the-post-bariatric-patient/), lows occur one to three hours after meals.

## Step-by-step approach

- Treat first: fast-acting oral glucose if the patient can swallow; intravenous dextrose or [glucagon](https://durgical.com/en/pharmacology/glucagon/) if not.
- In a patient with diabetes, find the reason: drug or dose, missed meal, exercise, alcohol, kidney function, new interacting drugs.
- In a patient without diabetes, document the Whipple triad with a laboratory glucose.
- Take a critical sample during a spontaneous low, or provoke it safely (supervised 72-hour fast or mixed-meal test).
- Read insulin, C-peptide, proinsulin, beta-hydroxybutyrate and the secretagogue screen together.
- Endogenous hyperinsulinism with a negative drug screen: localise the tumour (CT or MRI, endoscopic ultrasound, functional imaging).

## Reading the critical sample during hypoglycaemia

| Cause | Insulin | C-peptide | Sulfonylurea screen | Beta-hydroxybutyrate |
| --- | --- | --- | --- | --- |
| Injected insulin | High | Low | Negative | Low |
| Sulfonylurea or meglitinide | High | High | Positive | Low |
| Insulinoma | High | High | Negative | Low |
| IGF-2-secreting tumour | Low | Low | Negative | Low |
| Starvation, liver failure, adrenal insufficiency | Low | Low | Negative | High |

## Keys to the differential

- Alcohol blocks the liver's glucose production: hypoglycaemia after binge drinking can be mistaken for intoxication.
- Older people on sulfonylureas are at high risk: targets are relaxed and drugs with lower hypoglycaemia risk are preferred.
- In infants and young children, hypoglycaemia raises the possibility of inborn errors of metabolism or hormone deficiencies and needs a critical sample too.

## Next step / Initial management

- Treat with fast-acting carbohydrate and recheck glucose after about 15 minutes; follow with a meal or snack.
- Sulfonylurea-induced hypoglycaemia: admit and observe because it recurs; [octreotide](https://durgical.com/en/pharmacology/octreotide/) is used when it is refractory.
- Review the diabetes regimen after every severe episode and set safer targets when needed.
- Refer to endocrinology hypoglycaemia in a person without diabetes and recurrent severe hypoglycaemia in diabetes.

## Common traps

- **A low meter reading after meals proves hypoglycaemia**: in a well person with symptoms after meals, the label needs the Whipple triad.
- **Blood tests can wait until glucose has been given**: by then the critical moment is lost.
- **No prescribed sulfonylurea means no sulfonylurea**: it can be taken by mistake (a dispensing error) or covertly.
- **Sulfonylurea hypoglycaemia can go home once glucose is normal**: sulfonylureas act for a long time, especially in kidney failure, so hypoglycaemia recurs; the patient is observed.
- **No warning symptoms means no hypoglycaemia**: beta-blockers hide the warning symptoms.

## Test yourself

Think of the answer, then tap the question to see it.

## During hypoglycaemia, a nurse has a high insulin and a very low C-peptide. What is the explanation?

Injected insulin: commercial insulin has no C-peptide, and the high insulin suppresses the patient's own secretion.

## High insulin and high C-peptide with a positive sulfonylurea screen: what does this mean?

Hypoglycaemia caused by a sulfonylurea, which makes the beta cells release their own insulin (with its C-peptide).

## Why does a person with an insulinoma have a low beta-hydroxybutyrate during hypoglycaemia?

Insulin blocks fat breakdown and ketone production; with inappropriate insulin, ketones stay low even while fasting.

## An older man on glibenclamide is found confused with a low glucose and recovers after dextrose. Why not send him home?

Sulfonylureas act for a long time, especially with reduced kidney function, so hypoglycaemia recurs; he needs observation.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/endocrinology/hypoglycaemia-the-whipple-triad-insulin-and-c-peptide/)

## Elsewhere in DurgiPedia

- [Glucagon and the counter-regulatory hormones](https://durgical.com/en/physiology/glucagon-and-the-counter-regulatory-hormones/)
- [Glucagon signalling](https://durgical.com/en/biochemistry/topics/glucagon-signalling/)
- [Pancreatic neuroendocrine tumours](https://durgical.com/en/general-pathology/pancreatic-neuroendocrine-tumours/)

## Connections

## See it in 3D 1

The structures of Durgical's 3D anatomy where it is found.

- [Pancreas](https://durgical.com/en/anatomy/pancreas/)

## Related 5

- [Diagnosing diabetes and telling the types apart](https://durgical.com/en/endocrinology/diagnosing-diabetes-and-telling-the-types-apart/)
- [Diabetic ketoacidosis and the hyperosmolar hyperglycaemic state](https://durgical.com/en/endocrinology/diabetic-ketoacidosis-and-the-hyperosmolar-hyperglycaemic-state/)
- [Stimulate if too little, suppress if too much: dynamic tests](https://durgical.com/en/endocrinology/stimulate-if-too-little-suppress-if-too-much-dynamic-tests/)
- [When to think of an inherited endocrine syndrome: MEN1, MEN2 and their relatives](https://durgical.com/en/endocrinology/when-to-think-of-an-inherited-endocrine-syndrome-men1-men2-and-their-relatives/)
- [Adrenal insufficiency: primary or central?](https://durgical.com/en/endocrinology/adrenal-insufficiency-primary-or-central/)

## Related conditions 5

- [Hypoglycaemia (including insulin-induced)](https://durgical.com/en/conditions/hypoglycaemia/)
- [Insulinoma](https://durgical.com/en/conditions/insulinoma/)
- [Multiple endocrine neoplasia (MEN 1, 2A, 2B)](https://durgical.com/en/conditions/multiple-endocrine-neoplasia/)
- [Adrenal insufficiency](https://durgical.com/en/conditions/adrenal-insufficiency/)
- [Neonatal hypoglycaemia (including infant of a diabetic mother)](https://durgical.com/en/conditions/neonatal-hypoglycaemia/)

## In Pharmacology 4

- [Glucagon](https://durgical.com/en/pharmacology/glucagon/)
- [Insulins](https://durgical.com/en/pharmacology/classes/insulins/)
- [Sulfonylureas](https://durgical.com/en/pharmacology/classes/sulfonylureas/)
- [Octreotide](https://durgical.com/en/pharmacology/octreotide/)

[← All of endocrinology](https://durgical.com/en/endocrinology/)

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: [Hypoglycemia](https://www.ncbi.nlm.nih.gov/books/NBK534841/) (StatPearls (NCBI Bookshelf), 2022); [Non-Diabetic Hypoglycemia](https://www.ncbi.nlm.nih.gov/books/NBK573079/) (StatPearls (NCBI Bookshelf), 2023); [Insulinoma](https://www.ncbi.nlm.nih.gov/books/NBK544299/) (StatPearls (NCBI Bookshelf), 2025); [Factitious Hypoglycemia](https://www.ncbi.nlm.nih.gov/books/NBK542310/) (StatPearls (NCBI Bookshelf), 2023); [Biochemistry, C Peptide](https://www.ncbi.nlm.nih.gov/books/NBK526026/) (StatPearls (NCBI Bookshelf), 2023).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/endocrinology/hypoglycaemia-the-whipple-triad-insulin-and-c-peptide/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/endocrinology/hypoglycaemia-the-whipple-triad-insulin-and-c-peptide/
